SPRY Net Income Growth
-348.66%TTM
Period ending:
SPRY TTM Net Income YoY %%
397.49%-2524.54%
2021-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
SPRY net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 19 observations from Dec 31, 2021 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| -348.6578% | |
| -1,165.0224% | |
| -2,241.7604% | |
| -63.001% | |
| -7.0804% | |
| 68.5085% | |
| 114.7117% | |
| 20.3193% | |
| 15.9365% | |
| -17.2269% | |
| -56.7528% | |
| -142.6889% | |
| -116.6653% | |
| -85.5558% | |
| -71.3284% | |
| 9.9156% | |
| 14.6473% | |
| 22.4951% | |
| 36.3448% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All SPRY financial metrics · SPRY stock overview · How to interpret financial metrics
